Kelly Henderson

Kelly Henderson is an experienced regulatory affairs professional with a background in quality assurance and clinical development. Kelly has worked in various roles at companies like G1 Therapeutics, Digital Diagnostics, and University of Iowa. Kelly's expertise includes IND/NDA regulatory submissions, clinical protocols, FDA submissions, and quality management. Kelly holds an Executive MBA from The University of Iowa Tippie College of Business, an MS in Pharmacology & Cancer Biology from Duke University, and a BS in Chemistry from State University of New York at Oswego.